Ruidong Zhang

Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study

Limin Li, Tianyou Wang, X. Ju, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up of children with acute promyelocytic leukemia treated with Beijing Children’s Hospital APL 2005 protocol (BCH-APL 2005)

J. Xie, G. Feng, Min-Yuan Wu, 2019, Pediatric hematology and oncology.

Low expressions of ARS2 and CASP8AP2 predict relapse and poor prognosis in pediatric acute lymphoblastic leukemia patients treated on China CCLG-ALL 2008 protocol.

G. Deng, Min-Yuan Wu, Zhigang Li, 2015, Leukemia research.

Changes in the hepatitis B surface antibody in childhood acute lymphocytic leukaemia survivors after treatment with the CCLG‐ALL 2008 protocol

Huyong Zheng, Wei Lin, Yaguang Peng, 2020, Clinical and experimental immunology.

PRMT5-mediated H4R3sme2 Confers Cell Differentiation in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Jincheng Wang, Mei Mei, Huyong Zheng, 2019, Clinical Cancer Research.

Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia

Min-Yuan Wu, Zhigang Li, Chao Gao, 2017, Oncotarget.

Gene expression–based classification and regulatory networks of pediatric acute lymphoblastic leukemia

Huiling Xue, Lin Sun, Min-Yuan Wu, 2009 .

Quantitative monitoring of minimal residual disease in childhood acute lymphoblastic leukemia using TEL‐AML1 fusion transcript as a marker

Lei Cui, Min-Yuan Wu, Zhigang Li, 2018, Pediatric investigation.